Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

TGF-β signaling in T cells: roles in lymphoid and epithelial neoplasia

Oncogene volume 24, pages 5701–5712 (2005)Cite this article

Abstract

Transforming growth factor-β (TGF-β) plays an essential role in regulating the homeostasis of cells in the lymphoid lineage. TGF-β signaling is not required for normal thymopoiesis, but is essential for regulating the expansion, activation, and effector function of the mature CD4+ and CD8+ T cells in the peripheral lymphoid organs and target tissues. Recent studies in both mice and humans have elucidated an important and complex role for TGF-β in regulatory T-cell biology. Disruption of TGF-β signaling in T cells impairs the maintenance of regulatory T cells, results in the expansion of activated effector T cells, and is associated with the production of cytokines that have major effects on cells in their environment. While autoimmunity and inflammation are the principal phenotypes associated with the abrogation of TGF-β signaling in T cells in mice, emerging evidence now also directly links Smad-dependent TGF-β signaling in T cells to the suppression of epithelial neoplasia. The TGF-β receptor-activated Smad3 plays a critical role in mediating many of the inhibitory effects of TGF-β signaling in T cells, and has now been established as an important suppressor of leukemogenesis. These studies are increasing our awareness of the many complex mechanisms through which TGF-β signaling controls the pathogenesis of cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Ashcroft GS and Roberts AB . (2000). Cytokine Growth Factor Rev., 11, 125–131.

  • Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C and Roberts AB . (1999). Nat. Cell Biol., 1, 260–266.

  • Attisano L and Wrana JL . (2002). Science, 296, 1646–1647.

  • Bachman KE and Park BH . (2005). Curr. Opin. Oncol., 17, 49–54.

  • Baroni T, Carinci P, Bellucci C, Lilli C, Becchetti E, Carinci F, Stabellini G, Pezzetti F, Caramelli E, Tognon M and Bodo M . (2003). J. Periodontol., 74, 1447–1453.

  • Beck C, Schreiber H and Rowley D . (2001). Microsc. Res. Technol., 52, 387–395.

  • Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A, Burg J, Strand S, Kiesslich R, Huber S, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Galle PR, Blessing M, Rose-John S and Neurath MF . (2004). Immunity, 21, 491–501.

  • Becker C, Fantini MC, Wirtz S, Nikolaev A, Lehr HA, Galle PR, Rose-John S and Neurath MF . (2005). Cell Cycle, 4, 217–220.

  • Bottinger EP, Letterio JJ and Roberts AB . (1997). Kidney Int., 51, 1355–1360.

  • Bright JJ and Sriram S . (1998). J. Immunol., 161, 1772–1777.

  • Brown KA, Roberts RL, Arteaga CL and Law BK . (2004). Breast Cancer Res., 6, R130–R139.

  • Campbell JD, Cook G, Robertson SE, Fraser A, Boyd KS, Gracie JA and Franklin IM . (2001). J. Immunol., 167, 553–561.

  • Chantry D, Turner M and Feldmann M . (1989). Eur. J. Immunol., 19, 783–786.

  • Chen CH, Seguin-Devaux C, Burke NA, Oriss TB, Watkins SC, Clipstone N and Ray A . (2003). J. Exp. Med., 197, 1689–1699.

  • Chen RH, Chang MC, Su YH, Tsai YT and Kuo ML . (1999). J. Biol. Chem., 274, 23013–23019.

  • Chen W, Jin W, Tian H, Sicurello P, Frank M, Orenstein JM and Wahl SM . (2001). J. Exp. Med., 194, 439–453.

  • Christ M, McCartney-Francis NL, Kulkarni AB, Ward JM, Mizel DE, Mackall CL, Gress RE, Hines KL, Tian H and Karlsson S et al. (1994). J. Immunol., 153, 1936–1946.

  • Chrobak P . (2003). Acta Med. (Hradec Kralove), 46, 131–137.

  • Coste A, Lefaucheur JP, Wang QP, Lesprit E, Poron F, Peynegre R and Escudier E . (1998). Arch. Otolaryngol. Head Neck Surg., 124, 1361–1366.

  • D’Angeac AD, Dornand J, Emonds-Alt X, Jullien P, Garcia-Sanz JA and Erard F . (1991). J. Cell. Physiol., 147, 460–469.

  • Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y and Wang XF . (1999). Mol. Cell. Biol., 19, 2495–2504.

  • de Caestecker MP, Piek E and Roberts AB . (2000). J. Natl. Cancer Inst., 92, 1388–1402.

  • Downing JR . (2004). N. Engl. J. Med., 351, 528–530.

  • Dupuy d’Angeac A, Reme T, Monier S, Gao Q, Duperray C, Jullien P and Dornand J . (1993). J. Cell. Physiol., 154, 44–52.

  • Ebert EC . (1999). Clin. Exp. Immunol., 115, 415–420.

  • Eickelberg O, Pansky A, Koehler E, Bihl M, Tamm M, Hildebrand P, Perruchoud AP, Kashgarian M and Roth M . (2001). FASEB J., 15, 797–806.

  • Elliott RL and Blobe GC . (2005). J. Clin. Oncol., 23, 2078–2093.

  • Fahlen L, Read S, Gorelik L, Hurst SD, Coffman RL, Flavell RA and Powrie F . (2005). J. Exp. Med., 201, 737–746.

  • Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR and Neurath MF . (2004). J. Immunol., 172, 5149–5153.

  • Fox SW, Haque SJ, Lovibond AC and Chambers TJ . (2003). J. Immunol., 170, 3679–3687.

  • Fu T, Shen Y and Fujimoto S . (2000). Int. J. Cancer, 87, 680–687.

  • Fuchs O, Provaznikova D and Peslova G . (2005). Cas Lek Cesk, 144, 90–94.

  • Garba ML, Pilcher CD, Bingham AL, Eron J and Frelinger JA . (2002). J. Immunol., 168, 2247–2254.

  • Gorelik L, Constant S and Flavell RA . (2002). J. Exp. Med., 195, 1499–1505.

  • Gorelik L and Flavell RA . (2000). Immunity, 12, 171–181.

  • Gorelik L and Flavell RA . (2001). Nat. Med., 7, 1118–1122.

  • Gorelik L and Flavell RA . (2002). Nat. Rev. Immunol., 2, 46–53.

  • Gorham JD, Guler ML, Fenoglio D, Gubler U and Murphy KM . (1998). J. Immunol., 161, 1664–1670.

  • Haque SJ and Williams BR . (1998). Semin. Oncol., 25 (Suppl 1), 14–22.

  • Herrmann S and Abdi K . (1996). Ann. NY Acad. Sci., 795, 168–180.

  • Huang M, Sharma S, Zhu LX, Keane MP, Luo J, Zhang L, Burdick MD, Lin YQ, Dohadwala M, Gardner B, Batra RK, Strieter RM and Dubinett SM . (2002). J. Clin. Invest., 109, 931–937.

  • Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K and Silvennoinen O . (1995). Annu. Rev. Immunol., 13, 369–398.

  • Inge TH, Hoover SK, Susskind BM, Barrett SK and Bear HD . (1992). Cancer Res., 52, 1386–1392.

  • Iwamoto T, Oshima K, Seng T, Feng X, Oo ML, Hamaguchi M and Matsuda S . (2002). Histol. Histopathol., 17, 887–895.

  • Jacobsen SE, Keller JR, Ruscetti FW, Kondaiah P, Roberts AB and Falk LA . (1991). Blood, 78, 2239–2247.

  • Jacobsen SE, Ruscetti FW, Roberts AB and Keller JR . (1993). J. Immunol., 151, 4534–4544.

  • Kaklamani VG and Pasche B . (2004). Expert Rev. Anticancer Ther., 4, 649–661.

  • Kale VP and Vaidya AA . (2004). Stem Cells Dev., 13, 536–547.

  • Kao JY, Gong Y, Chen CM, Zheng QD and Chen JJ . (2003). J. Immunol., 170, 3806–3811.

  • Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB and Fauci AS . (1986a). J. Immunol., 137, 3855–3860.

  • Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB and Fauci AS . (1986b). J. Exp. Med., 163, 1037–1050.

  • Khattri R, Kasprowicz D, Cox T, Mortrud M, Appleby MW, Brunkow ME, Ziegler SF and Ramsdell F . (2001). J. Immunol., 167, 6312–6320.

  • Kim SJ and Letterio J . (2003). Leukemia, 17, 1731–1737.

  • Kuhn R, Schwenk F, Aguet M and Rajewsky K . (1995). Science, 269, 1427–1429.

  • Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM and Karlsson S . (1993). Proc. Natl. Acad. Sci. USA, 90, 770–774.

  • Kulkarni AB, Thyagarajan T and Letterio JJ . (2002). Curr. Mol. Med., 2, 303–327.

  • Kullberg MC, Jankovic D, Gorelick PL, Caspar P, Letterio JJ, Cheever AW and Sher A . (2002). J. Exp. Med., 196, 505–515.

  • Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y and Hirai H . (1998). Blood, 92, 4003–4012.

  • Laouar Y, Sutterwala FS, Gorelik L and Flavell RA . (2005). Nat. Immunol., 6, 600–607.

  • Larsson J, Blank U, Helgadottir H, Bjornsson JM, Ehinger M, Goumans MJ, Fan X, Leveen P and Karlsson S . (2003). Blood, 102, 3129–3135.

  • Larsson J, Blank U, Klintman J, Magnusson M and Karlsson S . (2005). Exp. Hematol., 33, 592–596.

  • Letterio JJ, Geiser AG, Kulkarni AB, Dang H, Kong L, Nakabayashi T, Mackall CL, Gress RE and Roberts AB . (1996). J. Clin. Invest., 98, 2109–2119.

  • Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB and Roberts AB . (1994). Science, 264, 1936–1938.

  • Letterio JJ and Roberts AB . (1996). J. Leukocyte Biol., 59, 769–774.

  • Letterio JJ and Roberts AB . (1997). Clin. Immunol. Immunopathol., 84, 244–250.

  • Letterio JJ and Roberts AB . (1998). Annu. Rev. Immunol., 16, 137–161.

  • Leveen P, Larsson J, Ehinger M, Cilio CM, Sundler M, Sjostrand LJ, Holmdahl R and Karlsson S . (2002). Blood, 100, 560–568.

  • Li AG, Lu SL, Zhang MX, Deng C and Wang XJ . (2004). Cancer Res., 64, 7836–7845.

  • Lin HK, Bergmann S and Pandolfi PP . (2004). Nature, 431, 205–211.

  • Lin JT, Martin SL, Xia L and Gorham JD . (2005). J. Immunol., 174, 5950–5958.

  • Long J, Matsuura I, He D, Wang G, Shuai K and Liu F . (2003). Proc. Natl. Acad. Sci. USA, 100, 9791–9796.

  • Lucas PJ, Kim SJ, Melby SJ and Gress RE . (2000). J. Exp. Med., 191, 1187–1196.

  • Lucas PJ, McNeil N, Hilgenfeld E, Choudhury B, Kim SJ, Eckhaus MA, Ried T and Gress RE . (2004). Cancer Res., 64, 6524–6529.

  • Lyakh LA, Sanford M, Chekol S, Young HA and Roberts AB . (2005). J. Immunol., 174, 2061–2070.

  • Mamura M, Lee W, Sullivan TJ, Felici A, Sowers AL, Allison JP and Letterio JJ . (2004). Blood, 103, 4594–4601.

  • Marie JC, Letterio JJ, Gavin M and Rudensky AY . (2005). J. Exp. Med., 201, 1061–1067.

  • Markowitz SD and Roberts AB . (1996). Cytokine Growth Factor Rev., 7, 93–102.

  • Martins-Green M, Boudreau N and Bissell MJ . (1994). Cancer Res., 54, 4334–4341.

  • McKarns SC and Kaminski NE . (2000). Immunopharmacology, 48, 101–115.

  • Miller A, Lider O, Roberts AB, Sporn MB and Weiner HL . (1992). Proc. Natl. Acad. Sci. USA, 89, 421–425.

  • Monteleone G, Del Vecchio Blanco G, Palmieri G, Vavassori P, Monteleone I, Colantoni A, Battista S, Spagnoli LG, Romano M, Borrelli M, MacDonald TT and Pallone F . (2004). Gastroenterology, 126, 674–682.

  • Mossalayi MD, Mentz F, Ouaaz F, Dalloul AH, Blanc C, Debre P and Ruscetti FW . (1995). Blood, 85, 3594–3601.

  • Moustakas A and Heldin CH . (2003). Genes Dev., 17, 2855–2859.

  • Moustakas A, Pardali K, Gaal A and Heldin CH . (2002). Immunol. Lett., 82, 85–91.

  • Mukamoto M and Kodama H . (2000). Vet. Immunol. Immunopathol., 77, 121–132.

  • Mule JJ, Schwarz SL, Roberts AB, Sporn MB and Rosenberg SA . (1988). Cancer Immunol. Immunother., 26, 95–100.

  • Nakamura K, Kitani A and Strober W . (2001). J. Exp. Med., 194, 629–644.

  • Ohta K, Yamagami S, Taylor AW and Streilein JW . (2000). Invest. Ophthalmol. Vis. Sci., 41, 2591–2599.

  • Pardoux C, Ma X, Gobert S, Pellegrini S, Mayeux P, Gay F, Trinchieri G and Chouaib S . (1999). Blood, 93, 1448–1455.

  • Park HB, Paik DJ, Jang E, Hong S and Youn J . (2004). Int. Immunol., 16, 1203–1213.

  • Philipp-Staheli J, Kim KH, Payne SR, Gurley KE, Liggitt D, Longton G and Kemp CJ . (2002). Cancer Cell, 1, 355–368.

  • Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H and Shevach EM . (2002). J. Exp. Med., 196, 237–246.

  • Piek E and Roberts AB . (2001). Adv. Cancer Res., 83, 1–54.

  • Plum J, De Smedt M, Leclercq G and Vandekerckhove B . (1995). J. Immunol., 154, 5789–5798.

  • Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM and Koff A . (1994). Genes Dev., 8, 9–22.

  • Roberts AB . (1999). Microbes. Infect., 1, 1265–1273.

  • Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF and Sporn MB . (1985). Proc. Natl. Acad. Sci. USA, 82, 119–123.

  • Roberts AB, Russo A, Felici A and Flanders KC . (2003). Ann. NY Acad. Sci., 995, 1–10.

  • Rosendahl A, Speletas M, Leandersson K, Ivars F and Sideras P . (2003). Int. Immunol., 15, 1401–1414.

  • Ruscetti FW and Palladino MA . (1991). Prog. Growth Factor Res., 3, 159–175.

  • Seedorf K . (1995). Metabolism, 44 (Suppl 4), 24–32.

  • Shevach EM, McHugh RS, Piccirillo CA and Thornton AM . (2001). Immunol. Rev., 182, 58–67.

  • Shi Y and Massague J . (2003). Cell, 113, 685–700.

  • Sitnicka E, Ruscetti FW, Priestley GV, Wolf NS and Bartelmez SH . (1996). Blood, 88, 82–88.

  • Smeltz RB, Chen J and Shevach EM . (2005). Immunology, 114, 484–492.

  • Sood R, Talwar-Trikha A, Chakrabarti SR and Nucifora G . (1999). Leukemia, 13, 348–357.

  • Sudarshan C, Galon J, Zhou Y and O’Shea JJ . (1999). J. Immunol., 162, 2974–2981.

  • Tada T, Ohzeki S, Utsumi K, Takiuchi H, Muramatsu M, Li XF, Shimizu J, Fujiwara H and Hamaoka T . (1991). J. Immunol., 146, 1077–1082.

  • Takahama Y, Letterio JJ, Suzuki H, Farr AG and Singer A . (1994). J. Exp. Med., 179, 1495–1506.

  • Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF and Taketo MM . (1998). Cell, 92, 645–656.

  • Tang J, Nuccie BL, Ritterman I, Liesveld JL, Abboud CN and Ryan DH . (1997). J. Immunol., 159, 117–125.

  • Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, Chen W, Wahl SM, Ledbetter S, Pratt B, Letterio JJ, Paul WE and Berzofsky JA . (2003). J. Exp. Med., 198, 1741–1752.

  • Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, Moses HL and Rowley DA . (1990). Proc. Natl. Acad. Sci. USA, 87, 1486–1490.

  • Touw IP, De Koning JP, Ward AC and Hermans MH . (2000). Mol. Cell. Endocrinol., 160, 1–9.

  • Ulloa L, Doody J and Massague J . (1999). Nature, 397, 710–713.

  • Wakefield LM and Roberts AB . (2002). Curr. Opin. Genet. Dev., 12, 22–29.

  • Wan YY and Flavell RA . (2005). Proc. Natl. Acad. Sci. USA, 102, 5126–5131.

  • Weiskirch LM, Bar-Dagan Y and Mokyr MB . (1994). Cancer Immunol. Immunother., 38, 215–224.

  • Wierenga AT, Schuringa JJ, Eggen BJ, Kruijer W and Vellenga E . (2002). Leukemia, 16, 675–682.

  • Williamson EA and Boswell HS . (1995). Curr. Opin. Hematol., 2, 29–40.

  • Wolfraim LA, Fernandez TM, Mamura M, Fuller WL, Kumar R, Cole DE, Byfield S, Felici A, Flanders KC, Walz TM, Roberts AB, Aplan PD, Balis FM and Letterio JJ . (2004). N. Engl. J. Med., 351, 552–559.

  • Xiao C, Shim JH, Kluppel M, Zhang SS, Dong C, Flavell RA, Fu XY, Wrana JL, Hogan BL and Ghosh S . (2003). Genes Dev., 17, 2933–2949.

  • Yamagiwa S, Gray JD, Hashimoto S and Horwitz DA . (2001). J. Immunol., 166, 7282–7289.

  • Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB and Deng C . (1999). EMBO J., 18, 1280–1291.

  • Yasukawa H, Sasaki A and Yoshimura A . (2000). Annu. Rev. Immunol., 18, 143–164.

  • Zhang L, Keane MP, Zhu LX, Sharma S, Rozengurt E, Strieter RM, Dubinett SM and Huang M . (2004). J. Biol. Chem., 279, 28315–28319.

  • Zhang XL, Topley N, Ito T and Phillips A . (2005). J. Biol. Chem., 280, 12239–12245.

  • Zhu Y, Richardson JA, Parada LF and Graff JM . (1998). Cell, 94, 703–714.

Download references

Acknowledgements

The author would like to acknowledge Dr Anita Roberts for the immeasurable support and outstanding mentoring that she has provided throughout his scientific career. Her unparalleled knowledge and expertise in TGF-β biology have provided the foundation for the work reviewed in this chapter. More importantly, they have been an inspiration to a generation of scientists who continue to explore the role of TGF-β in disease pathogenesis. Collectively, our challenge and our goal is to now translate this knowledge into novel strategies that will someday improve the outcome for patients living with cancer and with other diseases in which TGF-β plays such a critical role.

Author information

Authors and Affiliations

  1. The Laboratory of Cell Regulation and Carcinogenesis, The Center for Cancer Research, The National Cancer Institute, National Institutes of Health, Bethesda, 20892-5055, MD, USA

    John J Letterio

Authors
  1. John J Letterio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John J Letterio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Letterio, J. TGF-β signaling in T cells: roles in lymphoid and epithelial neoplasia. Oncogene 24, 5701–5712 (2005). https://doi.org/10.1038/sj.onc.1208922

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208922

Keywords

This article is cited by

Search

Advanced search

Quick links